Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.66 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.66 |
| ▸ | HTR2C | P28335 | 3/20 | 0.66 |
| ▸ | HTR2B | P41595 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035919 | 0.87 | TAAR1 (0.72) | HTR2ATAAR1HTR2CHTR2B | |
| SCHEMBL24959990 | 0.83 | HTR2A (0.68) | HTR2ATAAR1HTR2CHTR2B | |
| SCHEMBL29775337 | 0.82 | HTR2A (0.66) | HTR2ATAAR1HTR2C | |
| SCHEMBL23326313 | 0.82 | HTR2A (0.66) | HTR2ATAAR1HTR2C | |
| SCHEMBL27002092 | 0.82 | TAAR1 (0.70) | HTR2ATAAR1HTR2CMAPT | |
| SCHEMBL244435 | 0.81 | HTR2A (0.76) | HTR2ATAAR1HTR2CHTR2B | |
| SCHEMBL31731982 | 0.81 | HTR2A (0.70) | HTR2ATAAR1HTR2CHTR2B | |
| SCHEMBL27002011 | 0.80 | TAAR1 (0.68) | HTR2ATAAR1HTR2C | |
| SCHEMBL5809547 | 0.80 | HTR2A (1.00) | HTR2ATAAR1HTR2CHTR2B | |
| SCHEMBL29351348 | 0.80 | HTR2A (1.00) | HTR2ATAAR1HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059373-A1 | NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |